Secretory versus Degradative Autophagy: Unconventional Secretion of Inflammatory Mediators

Journal of Innate Immunity - Tập 5 Số 5 - Trang 471-479 - 2013
Shanya Jiang1, Nicolas Dupont1, Eliseo F. Castillo1, Vojo Deretić
1Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, N. Mex., USA

Tóm tắt

Autophagy (macroautophagy) is often defined as a degradative process and a tributary of the lysosomal pathway. In this context, autophagy carries out cytoplasmic quality control and nutritional functions by removing defunct or disused organelles, particulate targets and invading microbes, and by bulk digestion of the cytoplasm. However, recent studies indicate that autophagy surprisingly affects multiple secretory pathways. Autophagy participates in extracellular delivery of a number of cytosolic proteins that do not enter the conventional secretory pathway via the Golgi apparatus but are instead unconventionally secreted directly from the cytosol. In mammalian cells, a prototypical example of this manifestation of autophagy is the unconventional secretion of a major proinflammatory cytokine, IL-1β. This review examines the concept of secretory autophagy and compares and contrasts the role of autophagy in the secretion of IL-1α and IL-1β. Although IL-1α and IL-1β have closely related extracellular inflammatory functions, they differ in intracellular activation, secretory mechanisms and how they are affected by autophagy. This example indicates that the role of autophagy in secretion is more complex, at least in mammalian cells, than the simplistic view that autophagosomes provide carriers for unconventional secretion of cytosolic proteins.

Từ khóa


Tài liệu tham khảo

10.1083/jcb.200911149

10.1083/jcb.201106098

10.1083/jcb.200911154

10.1038/emboj.2011.398

10.1016/j.tcb.2012.04.008

10.1242/jcs.103630

10.1093/emboj/18.18.4949

10.1128/EC.00337-09

10.1016/j.cell.2007.06.029

10.1038/nrm2617

10.1016/j.ceb.2011.04.005

10.1146/annurev-cellbio-092910-154005

10.1038/nrd3802

10.1016/j.cell.2011.10.026

10.1126/science.1196371

10.1038/emboj.2011.413

10.1016/j.cell.2007.05.021

10.1016/j.devcel.2011.02.006

10.1016/j.cell.2011.06.022

10.1126/science.1205407

10.1016/j.devcel.2011.08.016

10.1016/j.cell.2011.07.021

10.1083/jcb.200803137

10.1091/mbc.12.11.3690

10.1111/j.1600-0854.2010.01086.x

10.1083/jcb.201003122

10.1016/j.coi.2011.10.006

10.1016/j.devcel.2007.12.006

10.1016/S0076-6879(05)03034-X

10.1074/jbc.M111.326256

10.2147/CHC.S21849

10.1016/j.immuni.2012.04.015

10.1126/science.1205405

10.1083/jcb.200507002

10.1016/j.molcel.2011.07.039

10.1038/nrm2083

10.1083/jcb.201001121

10.1038/nature07383

10.1038/nature09663

10.1038/ni.1980

10.1074/jbc.M110.202911

10.1038/ni.2215

10.1016/j.immuni.2005.10.004

10.1038/ni.2237

10.4049/jimmunol.1201946

10.1016/j.molcel.2011.07.037

10.1073/pnas.1008155107

10.1073/pnas.1210500109

10.1038/nm1603

10.1016/j.immuni.2012.01.018

10.2337/diabetes.53.1.99

10.1016/j.freeradbiomed.2008.09.025

10.1080/02713680601161238

10.1073/pnas.0807694106

10.1038/nature07416

10.1016/j.cell.2010.05.009